Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab

Clinical trial NCT02453776 · COMPLETED

Trial details

NCT number: NCT02453776
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Inflammatory Bowel Disease

Start date: 2015-05-01
Primary completion: 2018-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.